VWCE 抗体

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human esophagus cancer tissue using P12390(VWCE  Antibody) at dilution 1/30. (Original magnification: ×200)    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human gastric cancer tissue using P12390(VWCE  Antibody) at dilution 1/30. (Original magnification: ×200)    

  
  

**Background of VWCE Antibody**

The VWCE (Von Willebrand Factor Cleaving Enzyme) antibody is primarily associated with the detection and analysis of ADAMTS13. a metalloprotease responsible for cleaving von Willebrand factor (VWF) multimers. ADAMTS13 plays a critical role in regulating blood coagulation by preventing excessive platelet aggregation and microvascular thrombosis. Deficiencies or dysfunction of ADAMTS13. often due to autoimmune inhibitors (autoantibodies), are linked to thrombotic thrombocytopenic purpura (TTP), a life-threatening disorder characterized by microangiopathic hemolytic anemia and thrombocytopenia.

VWCE antibodies, including both autoantibodies against ADAMTS13 and diagnostic antibodies used in assays, are essential in clinical and research settings. Diagnostic antibodies help quantify ADAMTS13 activity or detect inhibitory antibodies in patient plasma, aiding TTP diagnosis and management. Research applications include studying VWF-ADAMTS13 interactions, mechanisms of thrombosis, and autoimmune responses. Therapeutic strategies, such as plasma exchange or immunosuppression, often target these antibodies to restore ADAMTS13 function. The study of VWCE antibodies continues to advance understanding of thrombotic disorders and refine diagnostic and therapeutic approaches.